PPT-Local Production and A ccess to Medicines

EMP Technical Briefing Seminar 1 November 2013 WHO HQ Geneva Zafar Mirza Public Health Innovation and Intellectual Property Unit Essential Medicines amp Health Products Department . A SUCCESS STORY. Christian Keambou Tiambo. 1*. , Raquel . Juliano. Soares. 2. and . Frederico. Lisita. 2. 1. University of Buea-. Cameroon. , . 2. Embrapa . Pantanal. - . Brasil. *PO Box 63 Buea – Cameroon, . Global context of drug regulation. Dr Lembit Rägo. Coordinator. Quality Assurance and Safety: Medicines. Essential Medicines and Health Products. World Health Organization. E-mail: . ragol@who.int. IPC. 11. th. Dec . 2015, . Geneva. . National Strategy for Pharmaceutical Manufacturing Development in Ethiopia. developing industry to improve access. P. eople everywhere have access to the essential medicines they need; that the medicines are safe, effective, and of good quality; and that the medicines are prescribed and used rationally.. and Upgrading in . China. Gary . Herrigel. Paul . Klapper. Professor in the College and Social Sciences Division. University of Chicago. Oslo Norway. March 20, 2017. . Department of Political Science. Some New Development. I P C Meeting, Copenhagen (through VC). Zafar Mirza. 18 June 2015, Brussels. . WHO/EC Project:. . “. Improving access to medical products in developing countries through building capacity for local production and related technology transfer”. Some New Development. I P C Meeting, Copenhagen (through VC). Zafar Mirza. 18 June 2015, Brussels. . WHO/EC Project:. . “. Improving access to medical products in developing countries through building capacity for local production and related technology transfer”. EMP - Technical Briefing Seminar. . 1 November, 2013. WHO HQ, Geneva. Zafar . Mirza. Public . Health, Innovation and Intellectual . Property Unit. Essential Medicines & Health Products Department . By Laura Christian, Linda Collins, . Maythiwan. . Kiatgrajai. , . Agathe. Merle, . Nayantara. . Mukherji. , Alissa . Quade. Outline. Methodology. Overview. Definitions. Harmful Effects. Extent of the Problem. 1. Impact of the “. Crown Report”. Broadening the public’s access to . medicines. Pre-Crown report . Medically qualified doctor prescribed. Pharmacist dispensed medicines. Other prescribers . Nurses. 2015, . Geneva. . National Strategy for Pharmaceutical Manufacturing Development in Ethiopia. developing industry to improve access. P. eople everywhere have access to the essential medicines they need; that the medicines are safe, effective, and of good quality; and that the medicines are prescribed and used rationally.. Some New Development. I P C Meeting, Copenhagen (through VC). Zafar Mirza. 18 June 2015, Brussels. . WHO/EC Project:. . “. Improving access to medical products in developing countries through building capacity for local production and related technology transfer”. S T AAR 101: W h a t P a r e n t s N ee d t o Know Grade s 3-5 Paren t I n f orma t i on Prese n t ed b y Bonner Elementary Con te nt S ta nd a rds - TE KS S T AAR w ill t e st the c David . Beran. Division of Tropical and Humanitarian Medicine. Geneva University Hospitals and University of Geneva. Advisor to the Board International Insulin Foundatio. n. 1. The Global Action Plan for the Prevention and Control of Noncommunicable Diseases 2013-2020. Basic enquiry answering. September . 2016. Session aims. Increase awareness of the Medicines Information (MI) services. UK. Wales. Increase awareness of the questions to ask an enquirer. Have practical experience using some resources which will be...